BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32679409)

  • 1. Time and frequency to observe fiducial markers in MLC-modulated fields during prostate IMRT/VMAT beam delivery.
    Xu Q; Tong X; Lin M; Chen X; ElDib A; Lin T; Chen L; Ma CC
    Phys Med; 2020 Aug; 76():142-149. PubMed ID: 32679409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing fiducial visibility on periodically acquired megavoltage and kilovoltage image pairs during prostate volumetric modulated arc therapy.
    Zhang P; Happersett L; Ravindranath B; Zelefsky M; Mageras G; Hunt M
    Med Phys; 2016 May; 43(5):2024. PubMed ID: 27147314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling of a novel technique to improve the visualisation of implanted fiducial markers for intra-fraction MV imaging of prostate VMAT targets.
    Aland T; Jones M; Aho J; Kairn T; Trapp J
    Biomed Phys Eng Express; 2021 Jul; 7(5):. PubMed ID: 34265752
    [No Abstract]   [Full Text] [Related]  

  • 4. Developing a MLC modifier program to improve fiducial detection for MV/kV imaging during hypofractionated prostate volumetric modulated arc therapy.
    Happersett L; Wang P; Zhang P; Mechalakos J; Li G; Eley E; Zelefsky M; Mageras G; Damato AL; Hunt M
    J Appl Clin Med Phys; 2019 Jun; 20(6):120-124. PubMed ID: 31116478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric adaptive IMRT driven by fiducial points.
    Crijns W; Van Herck H; Defraene G; Van den Bergh L; Slagmolen P; Haustermans K; Maes F; Van den Heuvel F
    Med Phys; 2014 Jun; 41(6):061716. PubMed ID: 24877811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SU-E-J-139: Feasibility of Using EPID for Real-Time Target Localization during Treatment.
    Xu Q; Lin M; Chen X; Tong X; Fan J; Dong Z; Chen L; Ma C
    Med Phys; 2012 Jun; 39(6Part8):3684. PubMed ID: 28518940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments.
    Korpics MC; Rokni M; Degnan M; Aydogan B; Liauw SL; Redler G
    J Appl Clin Med Phys; 2020 Mar; 21(3):184-191. PubMed ID: 31981305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Online adaptation and verification of VMAT.
    Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
    Med Phys; 2015 Jul; 42(7):3877-91. PubMed ID: 26133589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-guided radiotherapy in near real time with intensity-modulated radiotherapy megavoltage treatment beam imaging.
    Mao W; Hsu A; Riaz N; Lee L; Wiersma R; Luxton G; King C; Xing L; Solberg T
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):603-10. PubMed ID: 19735886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and clinical evaluation of automatic fiducial detection for tumor tracking in cine megavoltage images during volumetric modulated arc therapy.
    Azcona JD; Li R; Mok E; Hancock S; Xing L
    Med Phys; 2013 Mar; 40(3):031708. PubMed ID: 23464303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous MV-kV imaging for intrafractional motion management during volumetric-modulated arc therapy delivery.
    Hunt MA; Sonnick M; Pham H; Regmi R; Xiong JP; Morf D; Mageras GS; Zelefsky M; Zhang P
    J Appl Clin Med Phys; 2016 Mar; 17(2):473-486. PubMed ID: 27074467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric effects of multileaf collimator leaf width on intensity-modulated radiotherapy for head and neck cancer.
    Hong CS; Ju SG; Kim M; Kim JI; Kim JM; Suh TS; Han Y; Ahn YC; Choi DH; Nam H; Park HC
    Med Phys; 2014 Feb; 41(2):021712. PubMed ID: 24506603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of direct clinical consequences of MLC positional errors in volumetric-modulated arc therapy using 3D dosimetry system.
    Nithiyanantham K; Mani GK; Subramani V; Mueller L; Palaniappan KK; Kataria T
    J Appl Clin Med Phys; 2015 Sep; 16(5):296–305. PubMed ID: 26699311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
    Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample.
    Kopp RW; Duff M; Catalfamo F; Shah D; Rajecki M; Ahmad K
    Med Dosim; 2011; 36(4):365-72. PubMed ID: 21377863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fiducial detection algorithm for real-time image guided IMRT based on simultaneous MV and kV imaging.
    Mao W; Riaz N; Lee L; Wiersma R; Xing L
    Med Phys; 2008 Aug; 35(8):3554-64. PubMed ID: 18777916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer.
    Martin JM; Handorf EA; Price RA; Cherian G; Buyyounouski MK; Chen DY; Kutikov A; Johnson ME; Ma CM; Horwitz EM
    Med Dosim; 2015; 40(3):186-9. PubMed ID: 25595491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An error detection method for real-time EPID-based treatment delivery quality assurance.
    Alves VGL; Ahmed M; Aliotta E; Choi W; Siebers JV
    Med Phys; 2021 Feb; 48(2):569-578. PubMed ID: 33314247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential benefits of dosimetric VMAT tracking verified with 3D film measurements.
    Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
    Med Phys; 2016 May; 43(5):2162. PubMed ID: 27147328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric impact of multileaf collimator leaf width according to sophisticated grade of technique in the IMRT and VMAT planning for pituitary adenoma lesion.
    Chae SM; Lee KW; Son SH
    Oncotarget; 2016 Nov; 7(47):78119-78126. PubMed ID: 27806336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.